In patients with type 1 diabetes mellitus (T1DM) imaging studies have demonstrated an increased prevalence of left ventricular diastolic dysfunction and increased left ventricular mass (LVM) unrelated to arterial hypertension and ischemic heart disease. The aim of our study was to identify potential predictors of early subclinical changes in cardiac chamber size and function in such patients. Sixty-one middle-aged asymptomatic normotensive patients with T1DM were included in the study. Conventional and tissue Doppler echocardiography was performed and fasting serum levels of glucose, glycated hemoglobin (HbA1c), lipids, and creatinine were measured. We found 
INTRODUCTION
Diabetes mellitus has been increasingly recognised as an important risk factor for heart failure unrelated to arterial hypertension, ischemic and valvular heart disease [1, 2] . The entity was first described in 1972 as diabetic cardiomyopathy [3] . Many different mechanisms have been proposed and the etiology appears to be multifactorial [4, 5] . Most studies have included patients with type 2 diabetes mellitus, but the link between type 1 diabetes mellitus (T1DM) and heart failure has also been documented [6] [7] [8] [9] . In our previous work we showed that even asymptomatic middle-aged adults with T1DM have some structural and functional changes of both ventricles compared to the age-and gender-matched healthy controls [10] . However, only limited data exist about the contribution of diabetes duration, long-term glycemic control, body mass index as well as the frequently coexisting dyslipidemia and renal dysfunction to early adverse changes in the heart of patients with T1DM [11, 12] . The aim of our study was to find potential predictors of early structural and functional changes in asymptomatic middle-aged T1DM patients without ishemic, hypertensive and valvular heart disease.
MATERIALS AND METHODS

Study design and participants
The study was conducted at the Department of Cardiology and Angiology, University Medical Centre Maribor, Slovenia. It was approved by the National Medical Ethics Committee of the Republic of Slovenia (Medical Ethics Committee approval number 130/10/13). All participants signed an informed consent to participate in the study.
We prospectively enrolled 61 asymptomatic patients with T1DM who attended diabetic outpatient clinic of the University Medical Centre Maribor, Slovenia for more than five years and met the inclusion/exclusion criteria. The inclusion criteria were age between 30 and 55 years and the duration of T1DM of more than five years. The exclusion criteria were arterial hypertension, ischaemic heart disease, clinical signs of heart failure at enrolment and in the past, bundle branch block or non-sinus rhythm in the electrocardiogram (ECG) and advanced nephropathy (glomerular filtration rate below 60 ml/min). Based on the echocardiographic results we further excluded patients with left ventricular ejection fraction below 50%, left ventricular wall motion abnormalities, valvular stenoses of any degree, more than mild valvular regurgitations and low quality echocardiographic image.
Before enrolment all medical records of the included patients were verified and medical history obtained. Anthropometric measurements (weight, height) were taken during the physical examination in the morning after overnight fasting. Rigid stadiometer and digital scales were used to measure height and weight, respectively. Body mass index (BMI) was calculated as weight in kilograms devided by the square of height in meters. Patients with BMI ≥ 25 were classified as overweight and BMI ≥ 30 was defined as obesity. Patients were asked to bring home blood pressure measurements to the enrolment visit. Home blood pressure measurements were obtained by patients with an automated blood pressure monitor twice daily seven consecutive days prior to the enrolment. Ambulatory blood pressure was obtained in the presence of the investigator at enrolment using an automated blood pressure monitor. The average value of the two consecutive ambulatory measurements was saved for statistical analysis. All blood pressure measurements were obtained after five minutes of rest in the seated position. The presence of arterial hypertension was defined by the average home blood pressure ≥ 135/85 mmHg and the office blood pressure ≥ 140/90 mmHg. All patients with arterial hypertension including those receiving antihypertensive medications were excluded from the study.
The standard 12-lead ECG was recorded in the supine position under resting conditions. Patients with ischemic heart disease were excluded based on medical history, resting ECG changes and the presence of left ventricular regional wall motion abnormalities.
Echocardiography
Two-dimesional echocardiography was performed in all patients by a single experienced echocardiographer on the same ultrasound machine (iE33, Philips Medical Systems) and included detailed two-dimensional, pulsed wave Doppler and tissue Doppler (TDI) evaluation. All measurements were based on the recommendations of the American Society of Echocardiography and the European Association of Cardiovascular Imaging [13] [14] [15] .
Biplane area-length formula was used to calculate the maximal end-systolic volume of the left atrium. Linear method (Cube formula) based on left ventricular measurements in the parasternal long axis view was used to calculate left ventricular mass. Relative wall thickness was calculated as two times the posterior wall thickness devided by the left ventricular end-diastolic diameter. Left ventricular ejection fraction was calculated by the biplane modified Simpson´s method [13, 14] . Two-dimesional measurements were indexed to the body surface area (BSA).
Peak mitral and tricuspid inflow velocities were measured by the pulsed wave Doppler [15] . All Doppler measurements of the right ventricle were added the suffix -t.
Peak myocardial systolic and diastolic velocities were measured by TDI at the septal part of the mitral annulus (s´sept, e´sept, a´sept) and at the lateral part of the tricuspid annulus (s´t, e´t, a´t).
Myocardial acceleration during isovolumetric contraction (IVA) was calculated for both ventricles using TDI as the ratio between the peak isovolumetric velocity and the acceleration time.
Acceleration time was defined as the time interval from baseline to the peak isovolumetric velocity [15] . Three consecutive Doppler measurements were averaged for statistical analysis. All Doppler measurements were performed at the frame rate ≥ 150 Hz.
Laboratory measurements
Blood samples were obtained from all patients in the fasting state. Serum levels of glycosylated hemoglobin, glucose, creatinine, triglycerides and total cholesterol were measured. The results of glycosylated hemoglobin obtained at six month follow-up visits in the preceding five years were averaged to assess the long-term glycemic control. Glycosylated hemoglobin was measured by the ion-exchange high performance liquid chromatography (Bio-Rad Laboratories, USA) [16] . The isotope dilution mass spectrometry traceable enzymatic assay (Siemens Healthcare Diagnostics Inc., Newark, USA) was performed to measure serum creatinine. Glomerular filtration rate was calculated by the Modification of Diet in Renal Disease (MDRD) equation and indexed to the normalized body surface area of 1.73 m 2 [16] .
Triglycerides were measured by the enzymatic method (Siemens HealthCare Diagnostics Inc., Newark, USA) and total serum cholesterol by the cholesterol esterase enzymatic assay (Siemens HealthCare Diagnostics Inc., Newark, USA) [16] .
Statistical analysis
SPSS Statistics 22.0 (IBM Corp., Armonk, New York, USA) was used for statistical analysis.
Continuous variables were shown as means ± standard deviations. Shapiro-Wilk test confirmed normal distribution of continuous variables. Categorical variables were presented as percentages.
The degree of association between clinical/laboratory data and echocardiography measurements was demonstrated with the Pearson´s correlation coefficient (r). Kendall's tau was used to evaluate the trend of glycosylated hemoglobin during the five year period. Multiple linear regression analysis was performed to assess whether statistically significant bivariate correlations of body mass index with cardiac chambers size and function continues after adjustment for other observed confounders. P-value < 0.05 was considered statistically significant for all calculations.
RESULTS
Sixty-one patients with mean age of 44.1 ± 5.3 years were enrolled to the study. The study group consisted of 34 men (55.7 %) and 27 women (44.3%). Thirty patients (49.2%) were treated with continuous subcutaneous insulin infusion and 31 patients (50.8%) with multiple daily injections of insulin. Mean diabetes duration was 17.9 ± 7.8 years. Thirty patients (49.1%) were overweight and 13 patients (21.3%) were obese with a mean BMI of 26.9 ± 3.9. Mean systolic and diastolic blood pressure were 125.2 ± 9.6 mmHg and 78.7 ± 6.4 mmHg, respectively. Mean fasting glucose level was 6.7 ± 2.7 mmol/L. Mean glycosylated hemoglobin at enrolment and the mean five year average were 7.4 ± 1.1% and 7.2 ± 0.7%, respectively. The mean trend of glycosylated hemoglobin expressed by the Kendall´s tau was 0.0 ± 0.4. Mean glomerular filtration rate was 105.0 ± 23.3 ml/min/1.73 m 2 , mean serum levels of triglycerides and total cholesterol were 1.0 ± 0.6 mmol/L and 4.8 ± 0.8 mmol/L, respectively. Demographic and clinical data are presented in Table 1 .
Echocardiographic measurements are presented in e´sept and E/e´sept were 8.9 ± 1.9 cm/s and 9.2 ± 1.9, respectively and mean e´t and E/e´t were 13.4 ± 2.9 cm/s and 4.0 ± 1.1 cm/s, respectively.
Bivariate correlations of clinical and laboratory variables with cardiac chambers size are presented in Table 3 . For all observed parameters except BMI indexed values of chambers size were used for correlation analysis. The correlations with Doppler parameters are presented in Table 4 (Table 3 and 4 ).
In the multiple linear regression model after adjusting for age, diabetes duration and five-year average value of glycosylated hemoglobin, BMI remained significantly associated with left ventricular mass, left atrial volume and the mitral inflow Doppler ratio E/A ( Table 5 ). The association of BMI with e´t and E/e´t met borderline significance (p = 0.050 for e´t and p = 0.047 for E/e´t).
DISCUSSION
In our study BMI was the only variable consistently associated with early changes in cardiac structure and function in asymptomatic normotensive middle-aged patients with T1DM. Average five-year glycemic control was weakly associated with the noninvasive Doppler index of left ventricular filling pressure E/e´.
In studies including patients with T1DM left ventricular hypertrophy was an inconsistent finding and was more prevalent in patients with microalbuminuria (7, 18) . On the other hand left ventricular hypertrophy has been much more frequently observed in patients with type 2 diabetes mellitus (T2DM) as supported by a considerable amount of evidence (19, 20) . Less myocardial hypertrophy in T1DM compared with T2DM might be at least partly explained by the reduced insulin secretion capacity in T1DM, since insulin stimulates growth and hypertrophy of myocardial cells (21) . While chronic hyperglycemia promotes accumulation of advanced glycation end products and subsequent myocardial stiffning, in T2DM insulin resistance and hyperinsulinemia predominantly increase left ventricular mass (21, 22) . Since left ventricular structural changes evaluated by imaging studies were often mild in patients with T1DM, some authors even questioned the existence of type 1 diabetes-specific cardiomyopathy (23, 24 This might be due to the good average long-term glycemic control achieved by the frequent use of continuous subcutaneous insulin infusion and the absence of an overall trend in glycosylated hemoglobin over years (mean Kendall´s tau = 0.0 ± 0.4). Based on our results and previous findings we assume that in well-controlled T1DM chronic hyperglycemia per se induces only mild structural and functional cardiac changes, but makes the heart more vulnerable and susceptible to further and more extensive injury due to obesity and other noxious stimuli. This might be the reason for a better association of BMI than diabetes duration and glycosylated hemoglobin with cardiac remodelling in our patients. However, our results may not be applied to patients with a poor glycemic control. An increased susceptibility of diabetic heart to a more extensive damage has been already demonstrated in case of ischemic and reperfusion injury, which resulted in a significantly larger ischemic area in patietns with diabetes compared with the non-diabetic controls (33).
Although autoantibodies in T1DM were assumed to cause dilated phenotype with eccentric left ventricular remodelling and systolic dysfunction, convincing evidence is lacking (8, 34 Cardiac steatosis is a common finding in diabetes mellitus due to metabolic derangements. The uptake of fatty acids by myocardial cells exceeds the capacity of mytochondrial oxidation. The myocardial lipid overload produces lipotoxic intermediates that increase the production of reactive oxidative species and promote myocardial cell apoptosis [38] . In our patients serum triglycerides and total cholesterol levels were not significantly associated with cardiac structure and function.
This might be explained by the relatively normal lipid profile, especially low serum triglycerides.
In the observational study of Vestberg D et al. advanced chronic kidney failure was related to increased hospitalizations for heart failure in patients with T1DM [39]. We found a weak association of glomerular filtration rate with left and right atrial size but no correlation with observed functional parameters. The reason might be the exclusion of patients with advanced renal disease (GFR < 60 ml/min/1.73 m 2 ).
There are limitations of our study. The number of eligible patients was limited due to the restrictive exclusion criteria. However, we decided to select patients with T1DM without major comorbidities influencing cardiac chambers size and function. Coronary angiography was not performed to exclude coronary artery disease due to ethical issues. We excluded all symptomatic patients and patients with a history of ischemic heart disease, resting ECG changes or left ventricular wall motion abnormalities. Although the threshold of T1DM duration for the study entry was five years, the time of T1DM diagnosis was quite variable. Furthermore, we could not provide reliable data of weight stability and duration of obesity. Only selected laboratory data were collected as the emphasis of the study was to identify potentially reversible factors for development of diabetic cardiomyopathy. For instance, inflammatory parameters which might accelerate the development of diabetic heart disease were not studied. Another important limitation of the study is the use of non-corrected multiple testing in a realtively small sample. The study was cross-sectional and generated hypotheses, which warrent further research. The Doppler assessment of diastolic parameters has limitations, especially the biphasic distribution of the Doppler index E/A as well as the non-linear correlation of E/e´ with the invasive measurements of left ventricular filling pressure.
CONCLUSION
In our study only BMI was associated with early structural and functional changes in the heart of middle-aged asymptomatic patients with T1DM. Long-term glycemic control was associated with the noninvasive Doppler index of left ventricular filling pressure, but not with cardiac chambers size. Based on our results we hypothesise that overweight and obese middle-aged patients with T1DM might be more prone to the development of cardiomyopathy and that screening of this subset of patients with echocardiography should be recommended. However, as our study is crosssectional and hypothesis-generating, further studies are needed to confirm the causal relationship between obesity and cardiac dysfunction in patients with T1DM.
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